Last reviewed · How we verify
NCT06664944: TECHWISE
Technology Exposure and Child Health: Wellness Impact and Social Effects: An Observational Product Registry Study
trial in Mood in 912 participants. Completed in 13 April 2026.
13 April 2026
Quick facts
| Lead sponsor | Aura |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 912 |
| Start date | 15 November 2024 |
| Primary completion | 13 April 2026 |
| Estimated completion | 13 April 2026 |
| Sites | 1 location across United States |
Conditions studied
- Mood — all drugs for Mood →
- Depression Disorders — all drugs for Depression Disorders →
- Anxiety Disorders — all drugs for Anxiety Disorders →
- Sleep — all drugs for Sleep →
Sponsor
Aura — full company profile →
Who can join
Adults 8 to 17, any sex, with Mood or Depression Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to understand how children's mobile device usage (smartphones or tablets), including social media use and online games, are related to their mental wellness and mental health, as well as some aspects of their physical activity and sleep. This study is available to all children between the ages of 8 and 17 years and a parent/caregiver. Researchers will compare participant mobile device usage with their survey responses on sleep, stress, mental health, and physical activity, as well as their parent/caregiver's survey responses. Participants will: * run the Aura app with parental controls on their dedicated mobile device * complete monthly surveys * answer daily questions on mood, stress, sleep and physical activity The study is fully virtual. Duration is 3 months.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Technology Effects and Child Health: Wellness Impact and Social Effects (TECHWISE): Protocol for a Prospective, Observational, Real-World Study.
Kollins SH, Flannery J, Goetz K, Akre-Bhide S. · · 2025 · PMID 40424191 · DOI 10.2196/69358
Verify or expand the search:
- PubMed search for NCT06664944
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mood
Currently open trials in the same condition.
- NCT07228013 — Examining Effects of Active Plant Engagement on College Student Well-Being and Performance · NA · active not recruiting
- NCT07017023 — Combined Blood Pressure Medication and Activity Scheduling for Low Mood · EARLY_PHASE1 · recruiting
- NCT07033052 — Developing Resilience and Anxiety Management Through the Arts · NA · recruiting
- NCT06950424 — Effect of Black Cumin Seed Oil Supplementation on Cortisol, Stress and Mood · NA · active not recruiting
- NCT06716554 — Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, P · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06664944 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aura
- Last refreshed: 15 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06664944.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing